Drug profile · INN
betaxolol hydrochloride
BETOPTIC
betaxolol hydrochloride (BETOPTIC) is a beta-1 adrenergic receptor antagonist. Route of administration: ophthalmic. Current US regulatory status: approved.
Drug details — betaxolol hydrochloride
- US status
- approved
- Class
- —
- Route
- OPHTHALMIC
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
betaxolol hydrochloride (BETOPTIC) is a beta-1 adrenergic receptor antagonist. Route of administration: ophthalmic. Current US regulatory status: approved.
Key facts
Mechanism of action
Beta-1 adrenergic receptor antagonist
Primary target: Beta-1 adrenergic receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is betaxolol hydrochloride?
betaxolol hydrochloride (BETOPTIC) is a beta-1 adrenergic receptor antagonist. Route of administration: ophthalmic. Current US regulatory status: approved.
What is the brand name for betaxolol hydrochloride?
BETOPTIC is a marketed brand name for betaxolol hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of betaxolol hydrochloride?
betaxolol hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.